jRCT2041250143招募中不适用
A PHASE IIb, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED INDUCTION STUDY WITH AN ACTIVE TREATMENT EXTENSION TO ASSESS THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF RO7837195 IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
未提供0 个研究点目标入组 17 人开始时间: 待定
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 17
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
入排标准
- 年龄范围
- 18age old over 至 No limit（—）
- 性别
- All
入选标准
- •Diagnosis of ulcerative colitis (UC) established at least 3 months
- •Moderately to severely active UC assessed by mMS
- •Inadequate response, loss of response, or intolerance to conventional or advanced therapies for UC
排除标准
- •Prior extensive colonic resection, subtotal or total colectomy, or planned surgery for UC
- •Diagnosis of Crohn's disease or indeterminate colitis
- •Treatment with an advanced therapy targeted at tumor necrosis factor-like cytokine 1A (TL1a)
- •Inadequate response, loss of response, or intolerance to treatment of UC with an advanced therapy targeted at IL-12 and/or IL-23
研究者
相似试验
招募中
1 期
A PHASE 1B, MULTICENTER, RANDOMIZED, PLACEBO- CONTROLLED, DOUBLE-BLIND STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND BIOLOGICAL ACTIVITY OF TQS-168 IN SUBJECTS WITH AMYOTROPHIC LATERAL SCLEROSIS2023-504746-54-00Tranquis Therapeutics Inc.16
尚未招募
不适用
A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight and Type 2 Diabetes (Enith2)OBESITY OR OVERWEIGHT AND TYPE 2 DIABETESjRCT20612500901,600
尚未招募
不适用
A Study to Find Out How Effective and Safe JNJ-88545223 is for the Treatment of Participants With Active Psoriatic Arthritis (a Long-term Inflammatory Arthritis) (VELOTA)Arthritis, PsoriaticjRCT2031250700240
尚未招募
3 期
A clinical trial to study the effects of Brexpiprazole in comparison to Aripiprazole in patients suffering from Acute SchizophreniaCTRI/2024/06/069258Torrent Pharmaceuticals Ltd.304
尚未招募
3 期
A Phase III Study of GS101 Injection to Dupixent®NCT07386743Jiangsu Genscend Biopharmaceutical Co., Ltd572